Four* trials to watch over the next 12 months for pipeline Alzheimer's drugs
| Cassava Sciences | simufilam hydrochloride | filamin A inhibitor | III | Oral |
|---|---|---|---|---|
| Athira Pharma | fosgonimeton | hepatocyte growth factor activator | II/III | Subcutaneous |
| Alzheon Inc | valiltramiprosate | beta-amyloid protein 42 inhibitor | III | Oral |
